Research programme: dual carbonic anhydrase IX inhibitors - DualTPharmaAlternative Names: Dual CA IX inhibitors - DualTPharma; Sulfamide-nitroimidazole
Latest Information Update: 05 Aug 2016
At a glance
- Originator DualTPharma
- Class Antineoplastics; Nitroimidazoles; Sulfonamides
- Mechanism of Action Carbonic anhydrase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Cancer
Most Recent Events
- 05 Aug 2016 Investigation in Cancer in Netherlands (PO)